약물감시 시장 : 임상시험 단계별, 방법 유형별, 서비스 제공업체 유형별, 지역별

Global Pharmacovigilance Market is estimated to be valued at USD 8.03 Bn in 2025 and is expected to reach USD 14.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.

Figure. Pharmacovigilance Market Share (%), By Region 2025

The global pharmacovigilance market has been witnessing significant growth in the recent years. Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, prevention of adverse effects or any other drug-related problems. With the growing complexity of drug molecules and the introduction of novel therapies in the market, there is an increasing need to effectively monitor the safety of drugs post marketing. Stringent regulatory framework mandating drug safety monitoring along with increasing instances of adverse drug reactions is propelling the demand for pharmacovigilance services across the globe. Furthermore, the expanding generics market and outsourcing of clinical trials to emerging regions has further boosted the pharmacovigilance market.

Market Dynamics:

The global pharmacovigilance market is driven by the rising number of adverse drug reactions, stringent safety regulations for drug approval, increasing demand for efficacious therapies, and growing generics market. Stringent regulatory guidelines mandating post marketing surveillance is a key factor augmenting the demand for pharmacovigilance services. Furthermore, rising trend of drug recalls due to safety issues has compelled pharmaceutical companies to outsource their pharmacovigilance activities to specialized service providers. Moreover, increasing generics market in developed countries offer significant opportunities for the pharmacovigilance market players. However, budget constraints of small and midsize pharmaceutical companies and complexity of reporting drug safety data across regions pose challenges to market players.

Key Features of the Study:

• This report provides in-depth analysis of the global pharmacovigilance market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pharmacovigilance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, and IQVIA
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacovigilance market

Detailed Segmentation-

• By Clinical Trial Phases
  • Total Knee Replacement
  • Partial Knee Replacement
  • Kneecap Replacement
  • Revision Knee Replacement
• By Type of Method
  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Reporting
  • Cohort Event Monitoring
  • EHR Monitoring
• By Type of Service Provider
  • In-House
  • Contract Outsourcing
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Accenture
  • Cognizant Technology Solutions
  • Laboratory Corporation of America Holdings (LabCorp)
  • IBM Corporation
  • QuintilesIMS (IQVIA)
  • ICON plc
  • Capgemini
  • ITClinical
  • TAKE Solutions Ltd
  • BioClinica
  • PAREXEL International Corporation
  • Wipro Ltd
  • FMD K&L
  • Linical Accelovance
  • United BioSource Corporation (UBC)
  • PRA Health Sciences
  • ArisGlobal
  • Ennov Solutions Incc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Clinical Trial Phases
  • Market Snapshot, By Type of Method
  • Market Snapshot, By Type of Service Provider
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Pharmacovigilance Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Pharmacovigilance Market, By Clinical Trial Phases, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Pre-clinical Studies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinical Trial Phase I
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinical Trial Phase II
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinical Trial Phase III
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Post Marketing Surveillance or Phase IV
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Pharmacovigilance Market, By Type of Method, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Spontaneous Reporting
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intensified ADR Reporting
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Targeted Reporting
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cohort Event Monitoring
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• EHR Monitoring
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Pharmacovigilance Market, By Type of Service Provider, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• In-House
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Outsourcing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Pharmacovigilance Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Accenture
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Cognizant Technology Solutions
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Laboratory Corporation of America Holdings (LabCorp)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • IBM Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • QuintilesIMS (IQVIA)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • ICON plc
  • Capgemini
  • ITClinical
  • TAKE Solutions Ltd
  • BioClinica
  • PAREXEL International Corporation
  • Wipro Ltd
  • FMD K&L
  • Linical Accelovance
  • United BioSource Corporation (UBC)
  • PRA Health Sciences
  • ArisGlobal
  • Ennov Solutions Inc

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact